"paper"

COVID-19-associated risks and effects in myasthenia gravis (CARE-MG)

COVID-19 and Cerebrovascular Diseases: A Systematic Review and Perspectives for Stroke Management

SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with COVID-19

Societal Impact of Pain (SIP) is an international multi-stakeholder platform. Its long-term priorities are pain indicators, pain education, pain in employment, and pain research. This year traditional SIP Stakeholder Forum was on October 28th, 2020.

December's Executive Page is written by Elena Moro

December's Country of the Month is Albania

New onset of ocular myasthenia gravis in a patient with COVID-19: a novel case report and literature review

Severe COVID-19-related encephalitis can respond to immunotherapy.

Neurotropism of SARS-CoV-2 and its neuropathological alterations: Similarities with other coronaviruses

Disease burden and clinical severity of the first pandemic wave of COVID-19 in Wuhan, China

This year’s Annual Pain Forum was organised online due to the COVID-19 pandemic.

Genomic evidence for reinfection with SARS-CoV-2: a case study

Remdesivir for the Treatment of Covid-19 — Final Report

Fellow: Nicolas Jean Dubuisson, Belgium Term of the Fellowship: March – September 2019 Hosting department: Department of Neurology and Neurosurgery, Neuromuscular Disorders, University Medical Center (UMC) Utrecht, The Netherlands Supervisor: Dr. H.S. Goedee, PhD These 6 weeks in Utrecht were… Continue Reading

EJoN publishes EAN consensus statement for management of patients with neurological diseases during the COVID‐19 pandemic